At LBT, innovation is at the heart of everything we do. We are always looking for new opportunities where we can apply our expertise in image analysis and software development to create new technologies to improve healthcare delivery.
We have an active pipeline of products targeting the clinical unmet need. Our market driven approach aims to identify opportunities where we can achieve the greatest benefit and improve patient outcomes through:
STATUSIn Commercial Development
The Automated Plate Assessment System for antimicrobial resistance (APAS®-AMR) uses LBT Innovations ground-breaking AI image analysis platform to accurately read and interpret Antimicrobial susceptibility Tests (ASTs) for the detection of antimicrobial resistance (AMR).
LBT’s WoundVue technology uses artificial intelligence to assist clinicians in the assessment and care of chronic wounds.
STATUSProof of Concept
APAS® Pharma uses LBT’s cutting-edge artificial intelligent image analysis algorithms to automatically detect microbial growth on culture plates used for environmental monitoring.
LBT have conducted proof-of-concept research into developing a device able to detect the presence of biofilms in the presence of mammalian tissue.
Automated Gram Stain Assessment
Extension of LBT’s proven intelligent imaging analysis platform technology, APAS®. The application uses AI and digital pathology for the automation of gram stain image analysis.
LBT’s MicroStreak technology automates the process of culture plate streaking and inoculation for busy microbiology laboratories. This first in class technology initiated a new wave of automation in clinical microbiology.
Work with us
Do you have an idea and need an experienced partner to bring it to market?
At LBT, we are always looking for opportunities to bring new products to market
that improve healthcare delivery.